Insider · CIK 0001602225
Sara Zaknoen
Files at ATYR (aTYR PHARMA INC). First filing -, latest -.
In brief
Sara Zaknoen files SEC Form 4 as director at ATYR (aTYR PHARMA INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Sara Zaknoen has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 11, 2026 | ATYR aTYR PHARMA INC | AGrant or award Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | May 13, 2026 |
| May 1, 2025 | ATYR aTYR PHARMA INC | AGrant or award Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | May 2, 2025 |
Questions about Sara Zaknoen
Answered from the filings on this page, as of the latest one.
Is Sara Zaknoen buying or selling?
Sara Zaknoen has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Sara Zaknoen's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Sara Zaknoen has 0.
Where does Sara Zaknoen file Form 4?
Sara Zaknoen has filed Form 4 at ATYR (aTYR PHARMA INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.